GWAS Identifies Novel Susceptibility Loci on 6p21.32 and 21q21.3 for Hepatocellular Carcinoma in Chronic Hepatitis B Virus Carriers
View/ Open
Author
Li, Shengping
Qian, Ji
Zhao, Wanting
Dai, Juncheng
Bei, Jin-Xin
Foo, Jia Nee
McLaren, Paul J.
Li, Zhiqiang
Yang, Jingmin
Shen, Feng
Yang, Jiamei
Li, Shuhong
Pan, Shandong
Li, Wenjin
Zhai, Xiangjun
Zhou, Boping
Shi, Lehua
Chen, Xinchun
Chu, Minjie
Yan, Yiqun
Cheng, Shuqun
Shen, Jiawei
Jia, Weihua
Liu, Jibin
Yang, Jiahe
Wen, Zujia
Li, Aijun
Zhang, Guoliang
Luo, Xianrong
Qin, Hongbo
Chen, Minshan
Lin, Dongxin
Shen, Hongbing
Wang, Hongyang
Zeng, Yi-Xin
Wu, Mengchao
Hu, Zhibin
Shi, Yongyong
Liu, Jianjun
Zhou, Weiping
Yang, Yuan
Liu, Li
Wang, Yi
Wang, Jun
Zhang, Ying
Wang, Hua
Jin, Li
He, Lin
Note: Order does not necessarily reflect citation order of authors.
Published Version
https://doi.org/10.1371/journal.pgen.1002791Metadata
Show full item recordCitation
Li, Shengping, Ji Qian, Yuan Yang, Wanting Zhao, Juncheng Dai, Jin-Xin Bei, Jia Nee Foo, Paul J. McLaren, Zhiqiang Li, Jingmin Yang, Feng Shen, Li Liu, Jiamei Yang, Shuhong Li, Shandong Pan, Yi Wang, Wenjin Li, Xiangjun Zhai, Boping Zhou, Lehua Shi, Xinchun Chen, Minjie Chu, Yiqun Yan, Jun Wang, Shuqun Cheng, Jiawei Shen, Weihua Jia, Jibin Liu, Jiahe Yang, Zujia Wen, Aijun Li, Ying Zhang, Guoliang Zhang, Xianrong Luo, Hongbo Qin, Minshan Chen, Hua Wang, Li Jin, Dongxin Lin, Hongbing Shen, Lin He, Paul I. W. de Bakker, Hongyang Wang, Yi-Xin Zeng, Mengchao Wu, Zhibin Hu, Yongyong Shi, Jianjun Liu, and Weiping Zhou. 2012. Gwas identifies novel susceptibility loci on 6p21.32 and 21q21.3 for hepatocellular carcinoma in chronic hepatitis B virus carriers. PLoS Genetics 8(7): e1002791.Abstract
Genome-wide association studies (GWAS) have recently identified KIF1B as susceptibility locus for hepatitis B virus (HBV)–related hepatocellular carcinoma (HCC). To further identify novel susceptibility loci associated with HBV–related HCC and replicate the previously reported association, we performed a large three-stage GWAS in the Han Chinese population. 523,663 autosomal SNPs in 1,538 HBV–positive HCC patients and 1,465 chronic HBV carriers were genotyped for the discovery stage. Top candidate SNPs were genotyped in the initial validation samples of 2,112 HBV–positive HCC cases and 2,208 HBV carriers and then in the second validation samples of 1,021 cases and 1,491 HBV carriers. We discovered two novel associations at rs9272105 (HLA-DQA1/DRB1) on 6p21.32 (OR = 1.30, P = 1.13×\(10^{−19}\)) and rs455804 (GRIK1) on 21q21.3 (OR = 0.84, P = 1.86×\(10^{−8}\)), which were further replicated in the fourth independent sample of 1,298 cases and 1,026 controls (rs9272105: OR = 1.25, P = 1.71×\(10^{−4}\); rs455804: OR = 0.84, P = 6.92×\(10^{−3}\)). We also revealed the associations of HLA-DRB1*0405 and 0901*0602, which could partially account for the association at rs9272105. The association at rs455804 implicates GRIK1 as a novel susceptibility gene for HBV–related HCC, suggesting the involvement of glutamate signaling in the development of HBV–related HCC.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3395595/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:10456187
Collections
- HMS Scholarly Articles [17922]
Contact administrator regarding this item (to report mistakes or request changes)